Picture of Corcept Therapeutics Incorporated logo

CORT — Corcept Therapeutics Incorporated News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

Brief: Corcept Therapeutics Q4 EPS USD 0.26 Vs. IBES Estimate USD 0.43

Feb 26 (Reuters) - Corcept Therapeutics Q4 net income USD 30.746 million vs. IBES estimate USD 50.5 million.

Q4 revenue USD 181.89 million vs. IBES estimate USD 198.7 million

outlook FY revenue USD 900-950 million

Recent news on Corcept Therapeutics Incorporated

See all news